9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kobie, James J ^a   Alcena, Danielle C ^a   Zheng, Bo ^a   Bryk, Peter ^a   Mattiacio, Jonelle L ^a   Brewer, Matthew ^a   LaBranche, Celia ^b   Young, Faith M ^a   Dewhurst, Stephen ^a   Montefiori, David C ^b   Rosenberg, Alexander F ^a   Feng, Changyong ^a   Jin, Xia ^a   Keefer, Michael C ^a   Sanz, Ignacio ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9G4; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PHENOTYPE; SYSTEMIC LUPUS ERYTHEMATOSUS; VH4 34 GENE; VIRUS LOAD;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, NEUTRALIZING; AUTOANTIBODIES; B-LYMPHOCYTES; CD4 LYMPHOCYTE COUNT; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; VIRAL LOAD; YOUNG ADULT;

EID: 84860008585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035356     Document Type: Article

References (52)

1. Tomaras GD, Haynes BF, (2009) HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Current opinion in HIV and AIDS 4: 373-379.
2. Doria-Rose NA, Klein RM, Daniels MG, O'Dell S, Nason M, et al. (2010) Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables. J Virol 84: 1631-1636.
3. Sather DN, Armann J, Ching LK, Mavrantoni A, Sellhorn G, et al. (2009) Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J Virol 83: 757-769.
4. Simek MD, Rida W, Priddy FH, Pung P, Carrow E, et al. (2009) Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J Virol 83: 7337-7348.
5. Mikell I, Sather DN, Kalams SA, Altfeld M, Alter G, et al. (2011) Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Path 7: e1001251.
6. van Gils MJ, Euler Z, Schweighardt B, Wrin T, Schuitemaker H, (2009) Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression. AIDS 23: 2405-2414.
7. Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, et al. (2009) Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression. J Virol 83: 10269-10274.
8. Gray ES, Taylor N, Wycuff D, Moore PL, Tomaras GD, et al. (2009) Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J Virol 83: 8925-8937.
9. Haynes BF, Fleming J, St Clair EW, Katinger H, Stiegler G, et al. (2005) Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308: 1906-1908.
10. Verkoczy L, Kelsoe G, Moody MA, Haynes BF, (2011) Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Curr Opin Immunol 23: 383-390.
11. Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, et al. (2011) Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding. Science.
12. Scherer EM, Zwick MB, Teyton L, Burton DR, (2007) Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS 21: 2131-2139.
13. Singh H, Henry KA, Wu SS, Chruscinski A, Utz PJ, et al. (2011) Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies. AIDS 25: 1247-1257.
14. Scherl M, Posch U, Obermoser G, Ammann C, Sepp N, et al. (2006) Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease. Lupus 15: 865-872.
15. Douvas A, Takehana Y, Ehresmann G, Chernyovskiy T, Daar ES, (1996) Neutralization of HIV type 1 infectivity by serum antibodies from a subset of autoimmune patients with mixed connective tissue disease. AIDS Res Hum Retroviruses 12: 1509-1517.
16. Moir S, Fauci AS, (2009) B cells in HIV infection and disease. Nat Rev Immunol 9: 235-245.
17. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, et al. (2008) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205: 1797-1805.
18. Doria-Rose NA, Klein RM, Manion MM, O'Dell S, Phogat A, et al. (2009) Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J Virol 83: 188-199.
19. Morrow M, Valentin A, Little R, Yarchoan R, Pavlakis GN, (2008) A Splenic Marginal Zone-Like Peripheral Blood CD27+B220 B Cell Population Is Preferentially Depleted in HIV Type 1-Infected Individuals. AIDS Res Hum Retroviruses 24: 621-633.
20. Cappione A, III, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, et al. (2005) Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115: 3205-3216.
21. Bhat NM, Lee LM, van Vollenhoven RF, Teng NN, Bieber MM, (2002) VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype. The Journal of rheumatology 29: 2114-2121.
22. Stevenson FK, Smith GJ, North J, Glennie MG, Hamblin TJ, (1988) Use of a cross reacting anti-idiotype to identify normal counterparts of neoplastic cells. Nouvelle revue francaise d'hematologie 30: 299-300.
23. Stevenson FK, Longhurst C, Chapman CJ, Ehrenstein M, Spellerberg MB, et al. (1993) Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J Autoimmun 6: 809-825.
24. Potter KN, Li Y, Pascual V, Williams RC Jr, Byres LC, et al. (1993) Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment. The Journal of experimental medicine 178: 1419-1428.
25. Milner EC, Anolik J, Cappione A, Sanz I, (2005) Human innate B cells: a link between host defense and autoimmunity? Springer Semin Immunopathol 26: 433-452.
26. Cappione AJ, Pugh-Bernard AE, Anolik JH, Sanz I, (2004) Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol 172: 4298-4307.
27. Sanz I, Kelly P, Williams C, Scholl S, Tucker P, et al. (1989) The smaller human VH gene families display remarkably little polymorphism. The EMBO journal 8: 3741-3748.
28. Borretzen M, Chapman C, Stevenson FK, Natvig JB, Thompson KM, (1995) Structural analysis of VH4-21 encoded human IgM allo- and autoantibodies against red blood cells. Scand J Immunol 42: 90-97.
29. Pascual V, Victor K, Lelsz D, Spellerberg MB, Hamblin TJ, et al. (1991) Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol 146: 4385-4391.
30. Potter KN, Hobby P, Klijn S, Stevenson FK, Sutton BJ, (2002) Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol 169: 3777-3782.
31. Bhat NM, Bieber MM, Chapman CJ, Stevenson FK, Teng NN, (1993) Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. J Immunol 151: 5011-5021.
32. van Es JH, Gmelig Meyling FH, van de Akker WR, Aanstoot H, Derksen RH, et al. (1991) Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. The Journal of experimental medicine 173: 461-470.
33. Cappione A, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, et al. (2005) Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115: 3205-3216.
34. Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, et al. (2001) Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 108: 1061-1070.
35. Zheng NY, Wilson K, Wang X, Boston A, Kolar G, et al. (2004) Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. The Journal of clinical investigation 113: 1188-1201.
36. Mockridge CI, Rahman A, Buchan S, Hamblin T, Isenberg DA, et al. (2004) Common patterns of B cell perturbation and expanded V4-34 immunoglobulin gene usage in autoimmunity and infection. Autoimmunity 37: 9-15.
37. Mattiacio J, Walter S, Brewer M, Domm W, Friedman AE, et al. (2011) Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env. Vaccine 29: 2637-2647.
38. Mascola JR, D'Souza P, Gilbert P, Hahn BH, Haigwood NL, et al. (2005) Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J Virol 79: 10103-10107.
39. Bhat NM, Bieber MM, Yang YC, Leu YS, van Vollenhoven RF, et al. (2004) B cell lymphoproliferative disorders and VH4-34 gene encoded antibodies. Hum Antibodies 13: 63-68.
40. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM, (1999) Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmun 13: 347-355.
41. Dennison SM, Anasti K, Scearce RM, Sutherland L, Parks R, et al. (2011) Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens. J Virol 85: 1340-1347.
42. Catera R, Silverman GJ, Hatzi K, Seiler T, Didier S, et al. (2008) Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med 14: 665-674.
43. Jenks SA, Palmer E, Marin E, Sanz I, (2010) 9G4 Autoantibodies Dominate the Anti-Apoptotic Cell Autoimmune Response in SLE. Arthritis Rheum 62 Suppl 10, 486. ACR/ARHP 2010 poster presentation.
44. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, et al. (2004) Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
45. Klein U, Kuppers R, Rajewsky K, (1993) Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol 23: 3272-3277.
46. Klein U, Kuppers R, Rajewsky K, (1994) Variable region gene analysis of B cell subsets derived from a 4-year-old child: somatically mutated memory B cells accumulate in the peripheral blood already at young age. The Journal of experimental medicine 180: 1383-1393.
47. Haas A, Zimmermann K, Oxenius A, (2011) Antigen-Dependent and-Independent Mechanisms of T and B Cell Hyperactivation during Chronic Hiv-1 Infection. J Virol.
48. Zhou T, Georgiev I, Wu X, Yang ZY, Dai K, et al. (2010) Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329: 811-817.
49. Zachou K, Liaskos C, Rigopoulou E, Gabeta S, Papamichalis P, et al. (2006) Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 119: 203-212.
50. Forster J, Maier O, Lobbert J, Kaufmehl K, Streckert HJ, et al. (1996) Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection. Infection 24: 407-411.
51. Uthman IW, Gharavi AE, (2002) Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 31: 256-263.
52. Martinez V, Diemert MC, Braibant M, Potard V, Charuel JL, et al. (2009) Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 48: 123-132.